Introduction Despite widespread knowledge of the dangers of cigarette consumption,
smoking continues to be a public health concern. One compound that has shown potential …

Despite moderate success with pharmacological and behavioral treatments, smoking
relapse rates remain high, and many smokers report that smoking cues lead to relapse …

Background Cigarette smoking is a well-known public health concern, and there is an urgent
need to develop new treatments to reduce smoking or facilitate abstinence. One factor that is …

[Extract] Oxytocin, a nine amino acid neuropeptide, first discovered by Sir Heury Dale in
1906, is a potent modulator of a variety of brain functions including emotions, mood, social …

Intranasal oxytocin (INOT) has received attention as a treatment for substance use disorders
including tobacco dependence. However, it is unclear whether INOT-related effects differ by …

Background Preclinical and clinical evidence suggest that the neuropeptide oxytocin may be
of value in treating alcohol use disorder, by either reducing the rewarding effects of alcohol …

Substance use disorders blight the lives of millions of people and inflict a heavy financial
burden on society. There is a compelling need for new pharmacological treatments as …

Abstract Development of medications that attenuate symptoms of nicotine withdrawal may
be useful for facilitating smoking cessation. The neuropeptide oxytocin (OXY) decreases …

Recently, oxytocin (OXT) has been investigated for its potential therapeutic role in addiction.
OXT has been found to diminish various drug-seeking and drug-induced behaviors …

One of the crucial purposes of treating alcohol-dependent patients is to enhance their ability
to stay abstinent after detoxification therapy. Anxiety and stress vulnerability are the main …